Altitude sickness medical therapy: Difference between revisions

Jump to navigation Jump to search
Line 3: Line 3:
{{CMG}}
{{CMG}}
==Medical Therapy==
==Medical Therapy==
The classification of patients with acute mountain sickness as mild or moderate is based on the severity of headache and presence of other manifestation such as nausea, dizziness, fatigue or insomnia.
The classification of patients with acute mountain sickness as mild or moderate is based on the severity of headache and presence of other manifestation such as [[nausea]], [[dizziness]], [[fatigue]] or [[insomnia]].




The management of mild acute mountain sickness includes:
The management of mild acute mountain sickness includes:
# Discontinuation of Ascent.
# Discontinuation of Ascent.
# Treatment with Acetazolamide (250 mg q12h).
# Treatment with [[Acetazolamide]] (250 mg q12h).
# Descent: The patient should descend below the point at which the symptoms occured.
# Descent: The patient should descend below the point at which the symptoms occured.


Line 14: Line 14:
Similarly, following steps are recommended for management of moderate acute mountain sickness:
Similarly, following steps are recommended for management of moderate acute mountain sickness:
# Immediate Descent.
# Immediate Descent.
# Administration of Oxygen (2-4 L/min).
# Administration of [[Oxygen]] (2-4 L/min).
# Treatment with Dexamethasone (8 mg PO/IM/IV, then, 4 mg q6h).
# Treatment with [[Dexamethasone]] (8 mg PO/IM/IV, then, 4 mg q6h).
# Hyperbaric therapy: The patient is place in a portable altitude chamber or bag.
# Hyperbaric therapy: The patient is place in a portable altitude chamber or bag.



Revision as of 18:39, 20 November 2012

Altitude sickness Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Altitude Sickness from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X-ray

Echocardiography and Ultrasound

CT

MRI

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Altitude sickness medical therapy On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Altitude sickness medical therapy

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Altitude sickness medical therapy

CDC on Altitude sickness medical therapy

Altitude sickness medical therapy in the news

Blogs on Altitude sickness medical therapy

Directions to Hospitals Treating Altitude sickness

Risk calculators and risk factors for Altitude sickness medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Medical Therapy

The classification of patients with acute mountain sickness as mild or moderate is based on the severity of headache and presence of other manifestation such as nausea, dizziness, fatigue or insomnia.


The management of mild acute mountain sickness includes:

  1. Discontinuation of Ascent.
  2. Treatment with Acetazolamide (250 mg q12h).
  3. Descent: The patient should descend below the point at which the symptoms occured.


Similarly, following steps are recommended for management of moderate acute mountain sickness:

  1. Immediate Descent.
  2. Administration of Oxygen (2-4 L/min).
  3. Treatment with Dexamethasone (8 mg PO/IM/IV, then, 4 mg q6h).
  4. Hyperbaric therapy: The patient is place in a portable altitude chamber or bag.

References

Template:WH Template:WS